Title: PBM Overview
1- PBM Overview
- What is in this black box?
- Greg Rucinski RPh
2(No Transcript)
3PBM FUNCTIONS
- Process Claims
- Provide Pharmacy Network Discounts
- Provide Mail Order
- Provide High Cost Therapy Programs
- Provide Customer Service
- Provide Rebates
- Provide Information
4Misaligned Incentives
- These Program Participants Are Paid By
- The Prescription
- Manufacturers
- PBMs
- Pharmacy
- All are paid additional funds outside of your
control
5PBM Scrutiny
- TRENDS-Litigation
- Articles-almost every week
- Firms Paid to Trim Drug Costs Also Toil For Drug
Makers (Wall Street Journal) - When Is a Rebate a Kickback? (U.S. News World
Report)
6Quality Assurance Strategy
- QA Plan Design Effectiveness
- QA PBM and Claims Processing
- QA Manufacturer Revenue
- Assist Underwriting and Actuary
7Where Are The Dollars?
8UN-LEVERAGING PHARMACY TREND
9- Where to MANAGE?
- Contractual Holes- Missing Opportunities
- DUR,Plan Design Eligibility Disconnects
- Ongoing Savings Opportunities
10 Contract Discount Issues
14.22
35.45
Validation of Discounts
11What MAC Program?
Same Medication
12Brands need MACs Too!For Example Prozac 20mg
- Dista(Lilly) Package of 100 AWP3.11
- RePackager A AWP3.54
- RePackager B AWP3.56
- RePackager C AWP4.27
- 12 off any one of these drugs will not violate a
contract with the PBM!!
13MAC Alternates
0.10
0.41
2002 Data No MAC
14MAC REPRICE
Implied MAC Paid
Opportunities
15New Generic Entities
More Paid For Generic vs. Brand based on Co-Pay
16PBM Pricing Model
- Contracts No Longer Refer to U C
- -Typical Withhold 1.25/claim
- AWP based on 100 unit costs
- -Typical Withhold 0.50/claim
17Cost/Amount Billed Per Unit and Day
- Mail Order vs Retail
- Define the Discount
- Example SSRIs (Anti Depresents)
- Mail AWP 20 1.00
- Retail AWP 12 2.50
18(No Transcript)
19(No Transcript)
20Mail Order Analysis
21Rebate Issues
- Complex Contract Types
- Not easy to understand, payment based on AWP,
MAC, or unique criteria-Days of therapy - Market Share Based
- Based on Carrier, PBM, compared to National
Benchmarks.
22Rebate Overview
- PBMs revenue may be maximized through a greater
rebate - Administrators of these programs may be aligned
on the wrong incentive - High cost drugs with high rebates-who wins?
- Increasing Rebate Revenue does not always equal a
lower PMPM
23Best Price Issues
24Manufacturer Revenue Report
25Process Improvement
- Invalid NDCs
- Re Packs
- Phony DEAs
- Compound Rxs
- DAW Discount Grid
- QLL/QPC
26SOLUTION
- Be Informed
- Always QA the Program
- Beware of Mail Programs
- Read The Reports from PBM
- Ask Unit Cost Questions
- Communicate
27Products
- Basic Audit (Claim only)
- Full Audit (Claim Elig)
- Process Improvement Audit
- Day One Management Program
- Full PBM Replacement (TriScripts)
28 Pricing